0001217234-23-000206.txt : 20231002
0001217234-23-000206.hdr.sgml : 20231002
20231002195342
ACCESSION NUMBER: 0001217234-23-000206
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231002
FILED AS OF DATE: 20231002
DATE AS OF CHANGE: 20231002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seeto Reginald
CENTRAL INDEX KEY: 0001688485
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36536
FILM NUMBER: 231301209
MAIL ADDRESS:
STREET 1: C/O ARDELYX, INC.
STREET 2: 34175 ARDENWOOD BLVD, SUITE 200
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CareDx, Inc.
CENTRAL INDEX KEY: 0001217234
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 943316839
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 MARINA BLVD
STREET 2: 4TH FLOOR
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 415-287-2300
MAIL ADDRESS:
STREET 1: 8000 MARINA BLVD
STREET 2: 4TH FLOOR
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: XDx, Inc.
DATE OF NAME CHANGE: 20071010
FORMER COMPANY:
FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC
DATE OF NAME CHANGE: 20030203
4
1
wk-form4_1696290812.xml
FORM 4
X0508
4
2023-10-02
0
0001217234
CareDx, Inc.
CDNA
0001688485
Seeto Reginald
C/O CAREDX, INC.
8000 MARINA BOULEVARD, 4TH FLOOR
BRISBANE
CA
94005
1
1
0
0
See Remarks
0
Common Stock
2023-10-02
4
S
0
2818
6.9139
D
479164
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.83 to $6.99, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.
President and Chief Executive Officer
/s/ Reginald Seeto
2023-10-02